日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [(177)Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer

利用[(177)Lu]Lu-DOTA-MGS5进行CCK2R靶向肽受体放射性核素治疗小细胞肺癌患者

Zavvar, Taraneh Sadat; Santo, Giulia; Gruber, Leonhard; Kronthaler, Ariane; Hagenbuchner, Judith; Skvortsova, Ira; Piro, Inken; Steiger, Katja; Martinovic, Vladan; Minasch, Danijela; Löffler-Ragg, Judith; di Santo, Gianpaolo; Virgolini, Irene J; von Guggenberg, Elisabeth

Durvalumab Is Associated with Prolonged Progression-Free Survival, While Concomitant Chemoradiotherapy May Improve Both Locoregional and Local Control in Elderly Patients with Unresectable NSCLC Stage III: Subanalysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

Durvalumab 与延长无进展生存期相关,同时放化疗可改善老年不可切除 NSCLC III 期患者的局部区域控制和局部控制:奥地利放射肿瘤肺癌研究协会登记处 (ALLSTAR) 的亚组分析

Zehentmayr, Franz; Karner, Josef; Stana, Markus; Ruznic, Elvis; Zellinger, Barbara; Klebermass, Marisa; Purevdorj, Ayurzana; Gruber, Georg; Minasch, Danijela; Heilmann, Martin; Moosbrugger, Raphaela; Roeder, Falk; Grambozov, Brane

Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

免疫疗法改善了携带 Kirsten 大鼠肉瘤病毒突变的不可切除非小细胞肺癌 III 期患者的临床结果:奥地利放射肿瘤肺癌研究协会登记处 (ALLSTAR) 的亚组分析

Ruznic, Elvis; Klebermass, Marisa; Zellinger, Barbara; Langer, Brigitte; Grambozov, Brane; Purevdorj, Ayurzana; Karner, Josef; Gruber, Georg; Stana, Markus; Minasch, Danijela; Kirchhammer, Karoline; Steffal, Claudia; Stranzl, Heidi; Moosbrugger, Raphaela; Feurstein, Petra; Dieckmann, Karin; Zehentmayr, Franz

MLR and dMLR Predict Locoregional Control and Progression-Free Survival in Unresectable NSCLC Stage III Patients: Results from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)

MLR 和 dMLR 可预测不可切除的 NSCLC III 期患者的局部区域控制和无进展生存期:来自奥地利放射肿瘤肺癌研究协会注册中心 (ALLSTAR) 的结果

Hochreiter, Alexandra; Stana, Markus; Klebermass, Marisa; Ruznic, Elvis; Grambozov, Brane; Karner, Josef; Heilmann, Martin; Minasch, Danijela; Purevdorj, Ayurzana; Gruber, Georg; Moosbrugger, Raphaela; Röder, Falk; Zehentmayr, Franz

Prognosis versus Actual Outcomes in Stereotactic Radiosurgery of Brain Metastases: Reliability of Common Prognostic Parameters and Indices

脑转移瘤立体定向放射外科治疗的预后与实际结果:常用预后参数和指标的可靠性

Mangesius, Julian; Seppi, Thomas; Arnold, Christoph Reinhold; Mangesius, Stephanie; Kerschbaumer, Johannes; Demetz, Matthias; Minasch, Danijela; Vorbach, Samuel Moritz; Sarcletti, Manuel; Lukas, Peter; Nevinny-Stickel, Meinhard; Ganswindt, Ute

Systematic risk analysis of radiation pneumonitis in breast cancer: role of cotreatment with chemo-, endocrine, and targeted therapy

乳腺癌放射性肺炎的系统性风险分析:化疗、内分泌治疗和靶向治疗联合治疗的作用

Mangesius, Julian; Minasch, Danijela; Fink, Katharina; Nevinny-Stickel, Meinhard; Lukas, Peter; Ganswindt, Ute; Seppi, Thomas

Sector Irradiation vs. Whole Brain Irradiation After Resection of Singular Brain Metastasis-A Prospective Randomized Monocentric Trial

单发脑转移瘤切除术后,扇形照射与全脑照射的比较——一项前瞻性随机单中心试验

Kerschbaumer, Johannes; Pinggera, Daniel; Holzner, Bernhard; Delazer, Margarete; Bodner, Thomas; Karner, Elfriede; Dostal, Lucie; Kvitsaridze, Irma; Minasch, Danijela; Thomé, Claudius; Seiz-Rosenhagen, Marcel; Nevinny-Stickel, Meinhard; Freyschlag, Christian F